Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells

Clinical Immunology

Volumn 93, Issue 1, 1999, Pages 75-80

  Katsumata, Kazuaki ^a   Ikeda, Hitoshi ^a   Sato, Masayuki ^a   Ishizu, Akihiro ^a   Kawarada, You ^a   Kato, Hiroaki ^a   Wakisaka, Akemi ^a   Koike, Takao ^a   Yoshiki, Takashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cytokine regulation; Gene expression; Human endogenous retrovirus; Vascular endothelial cells; Vasculitis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; OPEN READING FRAME; PRIORITY JOURNAL; RETROVIRUS INFECTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULITIS; VIRUS EXAMINATION; VIRUS PATHOGENESIS;

EID: 0032844458     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4762     Document Type: Article

References (42)

1. Yoshiki T., Mellors R. C., Strand M., August J. T. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J. Exp. Med. 140:1974;1011-1027.
2. Yoshiki T., Hayasaka T., Fukatsu R., Shirai T., Itoh T., Ikeda H., Katagiri M. The structural proteins of murine leukimia virus and the pathogenesis of necrotizing arteritis and glomerulonephritis in SL/Ni mice. J. Immunol. 122:1979;1812-1820.
3. Brancato L., Itescu S., Skovron M. L., Solomon G., Winchester R. Aspects of the spectrum, prevalence and disease susceptibility determinants of Reiter's syndrome and related disorders associated with HIV infection. Rheumatol. Int. 9:1989;137-141.
4. Calabrese L. H. The rheumatic manifestations of infections with the human immunodeficiency virus. Semin. Arthritis Rheum. 18:1989;225-239.
5. Kalden J. R., Gay S. Retroviruses and autoimmune rheumatic diseases. Clin. Exp. Immunol. 98:1994;1-5.
6. Mayer-Siuata R., Keil L. B., DeBari V. A. Autoantibodies and circulating immune complexes infected in with human immunodeficiency virus. Med. Microbiol. Immunol. 177:1988;189-194.
7. Bloom E. J., Abrams D. I., Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. J. Am. Med. Assoc. 256:1986;491-493.
8. DeClerk L. S., Couttenye M. M., DeBroe M. E., Stevens W. J. Acquired immunodeficiency syndrome mimicking Sjögren's syndrome and systemic lupus erythematosus. Arthritis Rheum. 31:1988;272-275.
9. Berman A., Espinoza L. R., Diaz J. D., Aguilar J. L., Rolando T., Vasey F. B., Germain B. F., Lockey R. F. Rheumatic manifestations of human immunodeficiency virus infection. Am. J. Med. 85:1988;59-64.
10. Höllsberg P., Hafler D. A. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1993;1173-1182.
11. Green J. E., Hinrichs S. H., Vogal J., Jay G. Endocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice. Nature. 341:1989;72-74.
12. Iwakura Y., Tosu M., Yoshida E., Takiguchi M., Sato K., Kitajima I., Nishioka K., Yamamoto K., Takeda T., Hatanaka M., Yamamoto H., Sekiguchi T. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science. 253:1991;1026-1028.
13. Yamazaki H., Ikeda H., Ishizu A., Nakamaru Y., Sugaya T., Kikuchi K., Yamada S., Wakisaka A., Kasai N., Koike T., Hatanaka M., Yoshiki T. A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I. Int. Immunol. 9:1997;339-346.
14. Ishiguro N., Abe M., Seto K., Sakurai H., Ikeda H., Wakisaka A., Togashi T., Tateno M., Yoshiki T. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J. Exp. Med. 176:1992;981-989.
15. Kira J., Yamasaki K., Yamamoto I., Mizusawa H., Yoshino S., Kusunoki S., Yoshida T., Koyanagi Y., Tanaka Y., Kawano Y., Nakamura M., Tsuneyoshi M., Yamamoto N., Kobayashi T. Induction of chronic inflammatory arthropathy and mesenchymal tumors in rats infected with HTLV-I. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 16:1997;380-392.
16. O'Connell C. D., Cohen. M. The long terminal repeat sequences of a novel human endogenous retrovirus. Science. 226:1984;1204-1206.
17. O'Connell C., O'Brien S., Nash W. G., Cohen M. ERV3, a full-length human endogenous provirus: Chromosomal localization and evolutionary relationships. Virology. 138:1984;225-235.
18. Iwai K., Ishikura H., Kaji M., Sugiura H., Ishizu A., Takahashi C., Kato H., Tanabe T., Yoshiki T. Importance of E-selectin (ELAM-1) and sialyl Lewis (a) in the adhesion of pancreatic carcinoma cells to activated endothelium. Int. J. Cancer. 54:1993;972-977.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
20. Cohen M., Powers M., O'Connell C. D., Kato N. The nucleotide sequence of the env gene from the human provirus ERV3 and isolation and characterization of an ERV3-specific cDNA. Virology. 147:1985;449-458.
21. Siebert P. D., Larrick J. W. Competitive PCR. Nature. 359:1992;557-558.
22. Kato N., Pfeifer-Ohlsson S., Kato M., Larsson E., Rydnert J., Ohlsson R., Cohen M. Tissue-specific expression of human provirus ERV3 mRNA in human placenta: Two of the three ERV3 mRNAs contain human cellular sequences. J. Virol. 61:1987;2182-2191.
23. Löwer R., Löwer J., Kurth R. The viruses in all of us: Characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl. Acad. Sci. USA. 93:1996;5177-5184.
24. Venables P. J. W., Brookes S. M., Grifffiths D., Weiss R. A., Boyd M. T. Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology. 221:1995;589-592.
25. Cohen M., Kato N., Larsson E. ERV3 human endogenous provirus mRNAs are expressed in normal and malignant tissues and cells, but not in choriocarcinoma tumor cells. J. Cell. Biochem. 36:1988;121-128.
26. Takeuchi K., Katsumata K., Ikeda H., Minami M., Wakisaka A., Yoshiki T. Expression of endogenous retroviruses, ERV3 and λ4-1, in synovial tissues from patients with rheumatoid arthritis. Clin. Exp. Immunol. 99:1995;338-344.
27. Krieg A. M., Gourley M. F., Klinman D. M., Perl A., Steinberg A. D. Heterogeneous expression and coordinate regulation of endogenous retroviral sequences in human peripheral blood mononuclear cells. AIDS Res. Human Retrovir. 8:1992;1991-1998.
28. Andersson A.-C., Merza M., Venables P., Pontén F., Sundström J., Cohen M., Larsson E. Elevated levels of the endogenous retrovirus ERV3 in human sebaceous glands. J. Invest. Dermatol. 106:1996;125-128.
29. Katsumata K., Ikeda H., Sato M., Harada H., Wakisaka A., Shibata M., Yoshiki T. Tissue specific high-level expression of human endogenous retrovirus-R in the human adrenal cortex. Pathobiology. 66:1998;209-215.
30. Larsson E., Venables P. J. W., Andersson A.-C., Fan W., Rigby S., Bolting J., Öberg F., Cohen M., Nilsson K. Expression of the endogenous retrovirus ERV3 (HERV-R) during induced monocytic differentiation in the U-937 cell line. Int. J. Cancer. 67:1996;451-456.
31. Boyd M. T., Bax C. M. R., Bax B. E., Bloxam D. L., Weiss R. A. The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology. 196:1993;905-909.
32. Haraguchi S., Good R. A., Day N. K. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today. 16:1995;595-603.
33. Pinter A., Chen T.-E., Lowy A., Cortez N. G., Silagi S. Ecotropic murine leukemia virus-induced fusion of murine cells. J. Virol. 57:1986;1048-1054.
34. Bengtsson A., Blomberg J., Nived O., Pipkorn R., Toth L., Sturfelt G. Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly (amino acids) in patients with systemic lupus erythematosus. Arthritis Rheum. 39:1996;1654-1663.
35. Marrack P., Kushnir E., Kappler J. A maternally inherited superantigen encoded by a mammary tumor virus. Nature. 349:1991;524-526.
36. Frankel W. N., Rudy C., Cotfin J. M. Linkage of Mls genes to endogenous mammary tumor viruses of inbred mice. Nature. 349:1991;526-528.
37. Janeway C. Jr. Self superantigen. Cell. 63:1990;659-661.
38. Conrad B., Weissmahr R. N., Böni J., Arcari R., Schüpbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell. 90:1997;303-313.
39. Li J.-M., Fan W. S., Horsfall A. C., Anderson A. C., Rigby S., Larsson E., Venables P. J. W. The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block. Clin. Exp. Immunol. 104:1996;388-393.
40. Kato N., Shimotohno K., Vanleeuwen D., Cohen M. Human proviral mRNAs down regulated in choriocarcinoma encode a zinc finger protein related to Krüppel. Mol. Cell Biol. 10:1990;4401-4405.
41. Miller I. J., Bieker J. J. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins. Mol. Cell Biol. 13:1993;2776-2786.
42. Feng W. C., Southwood C. M., Bieker J. J. Analyses of β-thalassemia mutant DNA interactions with erythroid Krüppel-like factor (EKLF), an erythroid cell-specific transcription factor. J. Biol. Chem. 269:1994;1493-1500.